Stay Updated on LINDA's Availability

Sign up to be the first to know when LINDA becomes available in Canada.

Sign Up

Join the Waitlist

Fill out our form below to be the first to know when LINDA launches.

First name

Last name

Email

Phone number

I accept the Privacy Policy

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Contact Us Privacy Policy

LINDA is currently undergoing clinical trials for approval in Canada. LINDA is approved by Anvisa under notification number 82195910001 Risk Class II and is conducting additional clinical studies to expand its indications for use in Brazil.